Literature DB >> 21118705

A [polycation:heparin] complex releases growth factors with enhanced bioactivity.

Hunghao Chu1, Noah Ray Johnson, Neale Scott Mason, Yadong Wang.   

Abstract

Growth factors are potent molecules that regulate cell functions including survival, self renewal, differentiation and proliferation. High-efficacy delivery of growth factors will be a powerful tool for regenerative medicine. Decades of intense research have significantly advanced the field of controlled delivery. There is, however, still a great unmet need for new methods that can improve overall efficacy of growth factor delivery. Here, we report a new growth factor delivery vehicle formed by self assembly of heparin and a biocompatible polycation, poly(ethylene argininylaspartate diglyceride) (PEAD). Of the many heparin-binding growth factors, we chose FGF-2 and NGF to demonstrate the potential of the [PEAD:heparin] delivery vehicle. The delivery vehicle incorporates both growth factors with high efficiency, controls their release, maintains the bioactivity of FGF-2 and increases the bioactivity of NGF relative to bolus delivery. [PEAD:heparin] appears to be a promising delivery matrix for many heparin-binding growth factors and may lead to efficient growth factor delivery for a variety of diseases and disabilities.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118705     DOI: 10.1016/j.jconrel.2010.11.025

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  34 in total

1.  Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair.

Authors:  William C W Chen; Brandon G Lee; Dae Woo Park; Kyobum Kim; Hunghao Chu; Kang Kim; Johnny Huard; Yadong Wang
Journal:  Biomaterials       Date:  2015-09-02       Impact factor: 12.479

2.  Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction.

Authors:  Hassan K Awada; Noah R Johnson; Yadong Wang
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

3.  Dual delivery of vascular endothelial growth factor and hepatocyte growth factor coacervate displays strong angiogenic effects.

Authors:  Hassan K Awada; Noah R Johnson; Yadong Wang
Journal:  Macromol Biosci       Date:  2014-01-23       Impact factor: 4.979

4.  Biocompatibility of a coacervate-based controlled release system for protein delivery to the injured spinal cord.

Authors:  Britta M Rauck; Tabitha L Novosat; Martin Oudega; Yadong Wang
Journal:  Acta Biomater       Date:  2014-10-08       Impact factor: 8.947

5.  Controlled delivery of platelet-derived proteins enhances porcine wound healing.

Authors:  Daniel W Long; Noah R Johnson; Eric M Jeffries; Hidetaka Hara; Yadong Wang
Journal:  J Control Release       Date:  2017-03-14       Impact factor: 9.776

6.  Coacervate delivery of HB-EGF accelerates healing of type 2 diabetic wounds.

Authors:  Noah R Johnson; Yadong Wang
Journal:  Wound Repair Regen       Date:  2015-07-27       Impact factor: 3.617

Review 7.  Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.

Authors:  Hassan K Awada; Mintai P Hwang; Yadong Wang
Journal:  Biomaterials       Date:  2015-12-29       Impact factor: 12.479

8.  Engineered human myocardium with local release of angiogenic proteins improves vascularization and cardiac function in injured rat hearts.

Authors:  Fabiola Munarin; Rajeev J Kant; Cassady E Rupert; Amelia Khoo; Kareen L K Coulombe
Journal:  Biomaterials       Date:  2020-04-12       Impact factor: 12.479

9.  Sustained release of bone morphogenetic protein 2 via coacervate improves the osteogenic potential of muscle-derived stem cells.

Authors:  Hongshuai Li; Noah Ray Johnson; Arvydas Usas; Aiping Lu; Minakshi Poddar; Yadong Wang; Johnny Huard
Journal:  Stem Cells Transl Med       Date:  2013-07-24       Impact factor: 6.940

10.  Controlled delivery of heparin-binding EGF-like growth factor yields fast and comprehensive wound healing.

Authors:  Noah Ray Johnson; Yadong Wang
Journal:  J Control Release       Date:  2012-11-12       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.